Global Menopausal Hot Flashes Market: Industry Analysis and Forecast (2020-2026) By Treatment Type, Distribution Channel and Region

Global Menopausal Hot Flashes Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 3.5% during forecast period.

Global Menopausal Hot Flashes Market Overview:

Menopause is marked by hot flashes, which are the most common symptom. Hot flashes are assumed to be the result of changes in the hypothalamus, the portion of the brain that regulates body temperature; however, the exact reason is unknown.

Global Menopausal Hot Flashes Market Dynamics:

Rising population of elderly women is the major factor during forecast period. The primary driving factors in the menopausal heat flashes market are the rising incidence of menopausal hot flashes, the increasing number of new pharmacological approvals for treatment, and increased awareness about menopause health. Hot flashes are a quick sensation of warmth that mainly affects the chest, neck, and face. Hot flashes are a quick sensation of warmth that mainly affects the chest, neck, and face. Some of the primary variables leading to the robust growth of the menopausal hot flashes market are the high prevalence of fluctuating oestrogen levels and deteriorating musculoskeletal health among women. As a result, healthcare companies are ramping up their non-hormonal product clinical studies to satisfy a variety of needs. According to a study published in The Lancet Journal in 2018, 1 billion women will be over 50 years old in the next 25 years, and will be more likely to experience menopause or postmenopausal symptoms. Furthermore, over 73% of postmenopausal women have hot flashes (vasomotor symptoms), which can cause fatigue, reduced cognitive function, and sleep difficulties, lowering their quality of life and increasing their use of medical resources. Hot flashes produce flushing (redness of the skin) and profuse sweating. Menopause causes hot flashes, which occur when menstrual periods become erratic and eventually stop. Hot flashes are, in fact, the most prevalent symptom of menopausal transition (which includes stages such as pre-menopause, perimenopause, and post-menopause). The report has profiled sixteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Menopausal Hot Flashes Market Segment Analysis:

The Global Menopausal Hot Flashes Market is segmented on the basis of Treatment Type and Distribution Channel. Based on Treatment Type, the Estrogen segment from Hormonal Treatment is anticipated to hold the dominant market share during forecast period. Estrogen medications work by raising a woman's hormone levels and reducing the symptoms of menopause, such as hot flashes. Alora, Estraderm, Estrogel, Evamist, Vivelle, Climara, Divigel, and Estrace are some of the estradiol-containing medications approved by the USFDA to treat hot flashes. Non-estrogen medicines may have up to 70% of the efficacy of oestrogen therapy in managing hot flashes, according to several recent researches. The oestrogen segment dominates the menopausal hot flashes market, and this trend is expected to continue over the projection period. Estrogen drugs have a number of advantages, including improved vaginal health, reduced menopause symptoms, and the potential to improve bone and heart health. Novartis AG sells "Vivelle-DOT (estradiol transdermal system)," which is used to treat moderate to severe vasomotor symptoms associated with menopause, as well as moderate to severe vulvar and vaginal atrophy. As a result, the oestrogen segment is being driven by the rising incidence of menopausal hot flashes and technological developments in the production of new medications by market innovators. Global Menopausal Hot Flashes Market To know about the Research Methodology :- Request Free Sample Report

Global Menopausal Hot Flashes Market Regional Insights:

Global Menopausal Hot Flashes Market Regional InsightsNorth America is expected to dominate the market during forecast period. Because of the expanding geriatric women population with menopausal symptoms in the US and Canada, the market in North America is predicted to develop rapidly over the forecast period. The industry is predicted to grow in response to the rising demand for medical treatment during hot flashes. According to the National Centre for Biotechnology Information (NCBI), roughly 85% of postmenopausal women have experienced menopause-related symptoms (hot flashes). According to the North American Menopause Society, roughly 75% of North American women suffer hot flashes during pre-menopause, and around a quarter of them are bothered enough to seek medical help. Menopause is prevalent among the female elderly population, which increases overall market growth. In addition, technical improvements in the production of new pharmaceuticals, rising healthcare expenditures, and the presence of well-established healthcare infrastructure are all contributing to the regional market's growth. The report also helps in understanding Global Menopausal Hot Flashes Market dynamics, structure by analyzing the market segments and project the Global Menopausal Hot Flashes Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Menopausal Hot Flashes Market make the report investor’s guide.

Global Menopausal Hot Flashes Market Scope: Inquire before buying

Global Menopausal Hot Flashes Market

Global Menopausal Hot Flashes Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Menopausal Hot Flashes Market, Key players:

• Pfizer Inc. • Novartis AG • Novo Nordisk A/S • Allergan plc • Teva Pharmaceutical Industries Ltd. • Mylan N.V. • Hisamitsu Pharmaceutical Co., Inc. • Merck & Co., Inc. • GlaxoSmithKline plc • TherapeuticsMD, Inc • Eli Lilly and Company • Emcure Pharmaceuticals • Abbott Laboratories • Cipla • Theramax • Abbvie
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Menopausal Hot Flashes Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Menopausal Hot Flashes Market 3.4. Geographical Snapshot of the Menopausal Hot Flashes Market, By Manufacturer share 4. Global Menopausal Hot Flashes Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Menopausal Hot Flashes Market 5. Supply Side and Demand Side Indicators 6. Global Menopausal Hot Flashes Market Analysis and Forecast, 2019-2026 6.1. Global Menopausal Hot Flashes Market Size & Y-o-Y Growth Analysis. 7. Global Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 7.1.1. Hormonal Treatment 7.1.1.1.1. Estrogen 7.1.1.1.2. Progesterone 7.1.1.1.3. Estrogen-Progesterone Combination 7.1.2. Non-Hormonal Treatment 7.1.2.1.1. Antidepressant 7.1.2.1.2. Gabapentin 7.1.2.1.3. Pregabalin 7.1.2.1.4. Clonidine 7.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 7.2.1. Hospital Pharmacies 7.2.2. Retail Pharmacies 7.2.3. Online Pharmacies 8. Global Menopausal Hot Flashes Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 9.1.1. Hormonal Treatment 9.1.1.1. Estrogen 9.1.1.2. Progesterone 9.1.1.3. Estrogen-Progesterone Combination 9.1.2. Non-Hormonal Treatment 9.1.2.1. Antidepressant 9.1.2.2. Gabapentin 9.1.2.3. Pregabalin 9.1.2.4. Clonidine 9.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 9.2.1. Hospital Pharmacies 9.2.2. Retail Pharmacies 9.2.3. Online Pharmacies 10. North America Menopausal Hot Flashes Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 12. Canada Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 13. Mexico Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 14. Europe Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 15. Europe Menopausal Hot Flashes Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 17. France Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 18. Germany Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 19. Italy Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 20. Spain Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 21. Sweden Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 22. CIS Countries Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 23. Rest of Europe Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 24. Asia Pacific Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 25. Asia Pacific Menopausal Hot Flashes Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 27. India Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 28. Japan Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 29. South Korea Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 30. Australia Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 31. ASEAN Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 32. Rest of Asia Pacific Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 33. Middle East Africa Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 34. Middle East Africa Menopausal Hot Flashes Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 36. GCC Countries Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 37. Egypt Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 38. Nigeria Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 39. Rest of ME&A Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 40. South America Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 41. South America Menopausal Hot Flashes Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 43. Argentina Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 44. Rest of South America Menopausal Hot Flashes Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Menopausal Hot Flashes Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Pfizer Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Novartis AG 45.3.3. Novo Nordisk A/S 45.3.4. Allergan plc 45.3.5. Teva Pharmaceutical Industries Ltd. 45.3.6. Mylan N.V. 45.3.7. Hisamitsu Pharmaceutical Co., Inc. 45.3.8. Merck & Co., Inc. 45.3.9. GlaxoSmithKline plc 45.3.10. TherapeuticsMD, Inc 45.3.11. Eli Lilly and Company 45.3.12. Emcure Pharmaceuticals 45.3.13. Abbott Laboratories 45.3.14. Cipla 45.3.15. Theramax 45.3.16. Abbvie 46. Primary Key Insights

About This Report

Report ID 107313
Category Healthcare
Published Date Jun 2021
Updated Date
Contact Us